RANI
Rani Therapeutics Holdings, Inc
$0.97
+3.71%
2026-05-08
About Rani Therapeutics Holdings, Inc
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat rheumatoid arthritis; RT-116 which is in discovery stage for the treatment of obesity; RT-117 for rare diseases; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The have a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity; and Chugai Pharmaceutical Co., Ltd. to commercialize the Chugai Product combining Chugai's Compound, which is in development for hemophilia, and the RaniPill HC oral delivery device for use in humans. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.
Key Fundamentals
Forward P/E
-4.21
EPS (TTM)
$-0.45
ROE
-182.0%
Revenue Growth (YoY)
42.1%
Profit Margin
0.0%
Debt/Equity
10.40
Price/Book
2.84
Beta
0.76
Market Cap
$119.9M
Avg Volume (10D)
551K
Recent Breakout Signals
No recent breakout signals detected for RANI.
Recent Price Range (60 Days)
60D High
$1.41
60D Low
$0.68
Avg Volume
990K
Latest Close
$0.97
Get breakout alerts for RANI
Sign up for Breakout Scanner to receive daily notifications when RANI triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Rani Therapeutics Holdings, Inc (RANI) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors RANI daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. RANI operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.